These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 1409443

  • 1. The nature of tyrosinase isozymes.
    Tsukamoto K, Jiménez M, Hearing VJ.
    Pigment Cell Res; 1992; Suppl 2():84-9. PubMed ID: 1409443
    [No Abstract] [Full Text] [Related]

  • 2. Recent advances in the molecular biology of pigmentation: mouse models.
    Halaban R, Moellmann G.
    Pigment Cell Res; 1992; Suppl 2():67-78. PubMed ID: 1409441
    [No Abstract] [Full Text] [Related]

  • 3. The shift from physiological genetics to molecular genetics in the study of mouse tyrosinase.
    Quevedo WC, Holstein TJ.
    Pigment Cell Res; 1992; Suppl 2():57-60. PubMed ID: 1409439
    [No Abstract] [Full Text] [Related]

  • 4. Molecular structure of the tyrosinase gene.
    Takeuchi T.
    Pigment Cell Res; 1992; Suppl 2():61-6. PubMed ID: 1409440
    [No Abstract] [Full Text] [Related]

  • 5. Tyrosinase abundance and activity in murine hairbulb melanocytes of agouti mutants (C57BL/6J-a/a, Ay/a, and AwJ/AwJ).
    Kappenman KE, Dvoracek MA, Harvison GA, Fuller BB, Granholm NH.
    Pigment Cell Res; 1992; Suppl 2():79-83. PubMed ID: 1409442
    [No Abstract] [Full Text] [Related]

  • 6. Distinguishing between the catalytic potential and apparent expression of tyrosinase activities.
    Zhao H, Boissy RE.
    Am J Med Sci; 1994 Dec; 308(6):322-30. PubMed ID: 7985719
    [Abstract] [Full Text] [Related]

  • 7. Murine and human b locus pigmentation genes encode a glycoprotein (gp75) with catalase activity.
    Halaban R, Moellmann G.
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4809-13. PubMed ID: 1693779
    [Abstract] [Full Text] [Related]

  • 8. Temperature-sensitive tyrosinase associated with peripheral pigmentation in oculocutaneous albinism.
    King RA, Townsend D, Oetting W, Summers CG, Olds DP, White JG, Spritz RA.
    J Clin Invest; 1991 Mar; 87(3):1046-53. PubMed ID: 1900307
    [Abstract] [Full Text] [Related]

  • 9. The molecular basis of type I (tyrosinase-deficient) human oculocutaneous albinism.
    Giebel LB, Spritz RA.
    Pigment Cell Res; 1992 Mar; Suppl 2():101-6. PubMed ID: 1409411
    [No Abstract] [Full Text] [Related]

  • 10. The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): A model for understanding the molecular biology of melanin formation.
    Oetting WS.
    Pigment Cell Res; 2000 Oct; 13(5):320-5. PubMed ID: 11041207
    [Abstract] [Full Text] [Related]

  • 11. Molecular analysis of type I-A (tyrosinase negative) oculocutaneous albinism.
    Oetting WS, King RA.
    Hum Genet; 1992 Nov; 90(3):258-62. PubMed ID: 1487241
    [Abstract] [Full Text] [Related]

  • 12. Coexpression of wild-type tyrosinase enhances maturation of temperature-sensitive tyrosinase mutants.
    Halaban R, Cheng E, Hebert DN.
    J Invest Dermatol; 2002 Aug; 119(2):481-8. PubMed ID: 12190874
    [Abstract] [Full Text] [Related]

  • 13. Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins.
    Toyofuku K, Wada I, Valencia JC, Kushimoto T, Ferrans VJ, Hearing VJ.
    FASEB J; 2001 Oct; 15(12):2149-61. PubMed ID: 11641241
    [Abstract] [Full Text] [Related]

  • 14. DeoxyArbutin and its derivatives inhibit tyrosinase activity and melanin synthesis without inducing reactive oxygen species or apoptosis.
    Chawla S, Kvalnes K, deLong MA, Wickett R, Manga P, Boissy RE.
    J Drugs Dermatol; 2012 Oct; 11(10):e28-34. PubMed ID: 23134995
    [Abstract] [Full Text] [Related]

  • 15. Normal tyrosine transport and abnormal tyrosinase routing in pink-eyed dilution melanocytes.
    Potterf SB, Furumura M, Sviderskaya EV, Santis C, Bennett DC, Hearing VJ.
    Exp Cell Res; 1998 Oct 10; 244(1):319-26. PubMed ID: 9770375
    [Abstract] [Full Text] [Related]

  • 16. Distinct distal regulatory elements control tyrosinase expression in melanocytes and the retinal pigment epithelium.
    Murisier F, Guichard S, Beermann F.
    Dev Biol; 2007 Mar 15; 303(2):838-47. PubMed ID: 17196956
    [Abstract] [Full Text] [Related]

  • 17. Mammalian tyrosinase. A comparison of tyrosine hydroxylation and melanin formation.
    Hearing VJ, Ekel TM.
    Biochem J; 1976 Sep 01; 157(3):549-57. PubMed ID: 825109
    [Abstract] [Full Text] [Related]

  • 18. Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4.
    Costin GE, Valencia JC, Vieira WD, Lamoreux ML, Hearing VJ.
    J Cell Sci; 2003 Aug 01; 116(Pt 15):3203-12. PubMed ID: 12829739
    [Abstract] [Full Text] [Related]

  • 19. The pink-eyed dilution gene and the molecular pathogenesis of tyrosinase-positive albinism (OCA2).
    Manga P, Orlow SJ.
    J Dermatol; 1999 Nov 01; 26(11):738-47. PubMed ID: 10635616
    [No Abstract] [Full Text] [Related]

  • 20. Nitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinism.
    Onojafe IF, Adams DR, Simeonov DR, Zhang J, Chan CC, Bernardini IM, Sergeev YV, Dolinska MB, Alur RP, Brilliant MH, Gahl WA, Brooks BP.
    J Clin Invest; 2011 Oct 01; 121(10):3914-23. PubMed ID: 21968110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.